Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

- PMLiVE

Pfizer doses first patients with mRNA-based influenza vaccine

Available vaccine strains that match circulating influenza viruses offer only 40%-60% protection

- PMLiVE

Novavax’s COVID-19 vaccine candidate receives EC approval for use as a booster

Nuvaxovid induced a ‘robust antibody response’ when used as a heterologous third booster dose

Can Cinderella save us?

Locus Biosciences announces first patient treated in urinary tract infection trial

Around 80% of UTI cases are caused by E coli, often including strains that are antibiotic resistant

- PMLiVE

WHO/Europe urges endorsement of cervical cancer elimination roadmap

The initiative aims to fully vaccinate 90% of girls with the HPV vaccine by age 15

- PMLiVE

Metahumans – the future of empathetic education?

Technology is moving fast, and here at 11 London we’re moving with it. Now, Metahumans (powered by Unreal Engine 5) are just one of many innovations launching in the digital...

11 London

Article: From KOLs to KOIs – How to identify and engage the new healthcare influencers

Paul Reed and Basil Feilding investigate a new breed of KOLs with online influence and explain why pharma needs to join the conversation.

Inizio

- PMLiVE

Havas Health & You appoints Laura Mizrahi as chief creative officer of H4B Chelsea

Mizrahi joins the agency from her role as executive creative director at FCB Health NY

Women's health brand opportunities infographic

Women turn to brands for health advice after feeling sidelined by professionals

Women want brands to provide more health information, representing huge opportunities for brands to advocate for their consumers.

Thrive Agency

- PMLiVE

Thriving, not surviving – a hybrid mentality

By Joanne Wunder

- PMLiVE

Novartis announces $300m investment to boost development of next-generation biotherapeutics

The multi-year investment will be implemented across the company’s existing locations in Switzerland, Slovenia and Austria

- PMLiVE

WHO announces new global fund for pandemic prevention and preparedness

Over $1.4bn in financial commitments have already been announced and more are expected in the coming months

- PMLiVE

CuraSen Therapeutics doses first patients with novel combination therapy in dementia study

CuraSen Therapeutics doses first patients with novel combination therapy in dementia study

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links